Tyra Biosciences, Inc. (TYRA) NASDAQ

Currency In USD

Tyra Biosciences, Inc.

Address

2656 State Street

Carlsbad, CA 92008

United States of America (the)

Phone

619 728 4760

Website

https://www.tyra.bio

Sector

Healthcare

Industry

Biotechnology

Employees

First IPO Date

September 15, 2021

Key Executives

Name	Title	Pay	Year Born
Todd Harris	Co-Founder, CEO, President & Director	998,960	1979
Ronald V. Swanson	Chief Scientific Officer	536,188	1963
Bhavesh Ashar	Chief Operating Officer	551,017	1969
Ali D. Fawaz	General Counsel & Secretary	629,230	N/A
Daniel Bensen	Co-Founder & Chief Discovery Officer	737,643	1975
Alan Fuhrman	Chief Financial Officer	763,093	1957
Douglas Warner	Chief Medical Officer	764,683	1972
Julia Rueb	VP of Finance & Principal Accounting Officer	0	1986
Erik Goluboff	Senior Vice President of Clinical Development	0	N/A
Sarah Honig	Senior Vice President of Corporate Development & Strategy	0	N/A
Robert L. Hudkins	Chief Technology Officer	0	1955
Liz Pagano	Chief Human Resources Officer	0	N/A
Ralph William Charlton	Senior Vice President of Clinical Development	0	1971

Description

Tyra Biosciences, Inc. is a preclinical biopharmaceutical company focused on innovating treatments to tackle tumor resistance and enhance patient outcomes in oncology. Its flagship product candidate, TYRA-300, is a highly selective inhibitor of fibroblast growth factor receptor (FGFR)3, specifically engineered for the treatment of muscle-invasive bladder cancer. Beyond this, the company is advancing a pipeline of programs addressing other critical conditions, including FGFR2-related intrahepatic cholangiocarcinoma, FGFR3-associated achondroplasia, REarranged during transfection (RET) kinase aberrations, and various FGFR4-driven cancers. Tyra also leverages its proprietary SNAP platform, designed to accelerate structural drug design through an iterative molecular 'snapshot' approach. Founded in 2018, Tyra Biosciences maintains its headquarters in Carlsbad, California.